Verastem Oncology to Present at Upcoming Investor Conferences

Rhea-AI Summary

Verastem Oncology (Nasdaq: VSTM) announced that its management will present at two upcoming investor conferences. The H.C. Wainwright 23rd Annual Global Investment Conference is scheduled for September 13, 2021, at 7:00 a.m. ET, followed by the Cantor Virtual Global Healthcare Conference on September 27, 2021, at 4:00 p.m. ET. A webcast of both presentations will be available on the company's investor website, with an archive accessible for 90 days. Verastem focuses on developing new medicines for cancer treatment through innovative small molecule drugs.

BOSTON--(BUSINESS WIRE)-- Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients battling cancer, today announced that management will present virtually at the following upcoming investor conferences:

• H.C. Wainwright 23^rd Annual Global Investment Conference on Monday, September 13, 2021 at 7:00 a.m. Eastern Time

• Cantor Virtual Global Healthcare Conference on Monday, September 27, 2021 at 4:00 p.m. Eastern Time

A webcast of the presentations will be available on the investors section of the Company’s website at www.verastem.com. An archived presentation will be available for 90 days.

About Verastem Oncology

Verastem Oncology (Nasdaq: VSTM) (Verastem, Inc.) is a development-stage biopharmaceutical company committed to the development and commercialization of new medicines to improve the lives of patients diagnosed with cancer. Our pipeline is focused on novel small molecule drugs that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, including RAF/MEK inhibition and focal adhesion kinase (FAK) inhibition. For more information, please visit www.verastem.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210907005059/en/

Investors:

Ajay Munshi

Vice President, Corporate Development

+1 781-469-1579

amunshi@verastem.com

Sherri Spear

Argot Partners

+1 212-600-1902

sherri@argotpartners.com

Media:

Lisa Buffington

Corporate Communications

+1 781-292-4205

lbuffington@verastem.com

Source: Verastem Oncology

FAQ

When will Verastem Oncology present at the H.C. Wainwright Global Investment Conference?

Verastem Oncology will present at the H.C. Wainwright 23rd Annual Global Investment Conference on September 13, 2021, at 7:00 a.m. ET.

What time is Verastem's presentation at the Cantor Virtual Global Healthcare Conference?

Verastem's presentation at the Cantor Virtual Global Healthcare Conference is scheduled for September 27, 2021, at 4:00 p.m. ET.

Where can I watch the Verastem Oncology presentations?

The presentations will be available via webcast on Verastem Oncology's investor website at www.verastem.com.

How long will the presentations be archived for viewing?

The archived presentations will be available for 90 days after the live events.

What is the focus of Verastem Oncology's drug development?

Verastem Oncology is focused on developing novel small molecule drugs that inhibit key signaling pathways promoting cancer cell survival and tumor growth.